Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA, Kuban DA, Hancock SL, Smith CD.

JAMA. 1999 May 5;281(17):1598-604.

PMID:
10235152
2.

A systematic overview of radiation therapy effects in prostate cancer.

Nilsson S, Norlén BJ, Widmark A.

Acta Oncol. 2004;43(4):316-81. Review.

PMID:
15303499
3.

Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy.

Perez CA, Hanks GE, Leibel SA, Zietman AL, Fuks Z, Lee WR.

Cancer. 1993 Dec 1;72(11):3156-73. Review.

6.
7.

Radiation for prostate cancer: use of biochemical failure as an endpoint following radiotherapy.

Kuban DA, Thames HD, Levy LB.

World J Urol. 2003 Sep;21(4):253-64. Epub 2003 Aug 16. Review.

PMID:
12923658
8.

Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review.

Sutcliffe P, Hummel S, Simpson E, Young T, Rees A, Wilkinson A, Hamdy F, Clarke N, Staffurth J.

Health Technol Assess. 2009 Jan;13(5):iii, xi-xiii 1-219. doi: 10.3310/hta13050. Review.

9.

Clinical Potential of Statins in Prostate Cancer Radiation Therapy.

Hutchinson J, Marignol L.

Anticancer Res. 2017 Oct;37(10):5363-5372. Review.

PMID:
28982844
10.

An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review.

Raymond E, O'Callaghan ME, Campbell J, Vincent AD, Beckmann K, Roder D, Evans S, McNeil J, Millar J, Zalcberg J, Borg M, Moretti K.

Radiat Oncol. 2017 Mar 21;12(1):56. doi: 10.1186/s13014-017-0786-z. Review.

11.

Prostate cancer clinical trial end points: "RECIST"ing a step backwards.

Scher HI, Morris MJ, Kelly WK, Schwartz LH, Heller G.

Clin Cancer Res. 2005 Jul 15;11(14):5223-32. Review.

12.

Predictive models in external beam radiotherapy for clinically localized prostate cancer.

Roach M 3rd, Waldman F, Pollack A.

Cancer. 2009 Jul 1;115(13 Suppl):3112-20. doi: 10.1002/cncr.24348. Review.

13.

The effect of bicycling on PSA levels: a systematic review and meta-analysis.

Jiandani D, Randhawa A, Brown RE, Hamilton R, Matthew AG, Kuk JL, Alibhai SM, Tufts E, Santa Mina D.

Prostate Cancer Prostatic Dis. 2015 Sep;18(3):208-12. doi: 10.1038/pcan.2015.16. Epub 2015 May 5. Review.

PMID:
25939515
14.

A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer.

Diez P, Vogelius IS, Bentzen SM.

Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1066-71. doi: 10.1016/j.ijrobp.2009.06.013. Epub 2009 Oct 31. Review.

15.

Prostate cancer. Who is best benefited by external beam radiation therapy?

Hartford AC, Zietman AL.

Hematol Oncol Clin North Am. 1996 Jun;10(3):595-610. Review.

PMID:
8773499
16.

An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy.

Bristow RG, Berlin A, Dal Pra A.

Br J Radiol. 2014 Mar;87(1035):20130753. doi: 10.1259/bjr.20130753. Epub 2014 Feb 3. Review.

17.

Supplemental Content

Support Center